Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T18:48:03.102Z.
Calculation as of: 2026-10-06T18:48:03.102Z.
Quote observation: 2026-10-06T18:45:11.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: ad03cc2eaddb42082332b148aee8d6851fa015397d59a0785f41cacae5aa3ea4
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Starling Oncology, Inc.
Market Cap
$656.34M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$659.50M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$662.92M
Free Cash Flow Yield
6.12%
TTM Avg
8.57%
3Y Avg
5.30%
5Y Avg
5.30%
Market Cap
$668.99M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$636.65M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$640.29M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Starling Oncology, Inc. (STLN) | $656.34M | N/A | N/A | N/A | N/A |
| ArriVent BioPharma, Inc. (AVBP)vs › | $659.50M | N/A | N/A | N/A | N/A |
| MiMedx Group, Inc. (MDXG)vs › | $662.92M | 6.12% | 8.57% | 5.30% | 5.30% |
| Annexon, Inc. (ANNX)vs › | $670.94M | N/A | N/A | N/A | N/A |
| Helus Pharma Inc. (HELP)vs › | $668.81M | N/A | N/A | N/A | N/A |
| OmniAb, Inc. (OABI)vs › | $635.70M | N/A | 0.14% | 0.13% | 0.13% |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $668.99M | N/A | N/A | N/A | N/A |
| Aura Biosciences, Inc. (AURA)vs › | $636.65M | N/A | N/A | N/A | N/A |
| Prime Medicine, Inc. (PRME)vs › | $640.29M | N/A | N/A | N/A | N/A |
| Zevra Therapeutics, Inc. (ZVRA)vs › | $629.87M | 5.17% | 2.85% | 2.85% | 4.02% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
